Back
Corporate News
Lord’s Mark Industries projects Rs 2000 crore revenue by 2028, prioritizing healthcare expansion
21-Aug-2026, 08:53
Lord’s Mark Industries Limited anticipates total revenue exceeding Rs 2000 crore by fiscal year 2028, targeting a Profit After Tax of 10-11%, according to a recent investor conference call. The company’s Q1 revenue was split with 55% attributed to its In Vitro Diagnostics (IVD) and MedTech segments, and 45% from Renewable Energy, which currently holds an order book of approximately Rs 3000 crore. Management highlighted a strategic focus on the healthcare/MedTech segment, driven by its proprietary technologies and higher margins, while also continuing to develop and acquire technologies like a recent breast cancer testing technology from C-MET. Lord’s Mark is exploring options to enter the hospital business, including developing a new facility or acquiring and converting an existing one, with a potential launch by March 2027, and is actively pursuing inclusion of preventive healthcare products in the Ayushman Bharat scheme.
Lord’s Mark Industries Limited anticipates total revenue exceeding Rs 2000 crore by fiscal year 2028, targeting a Profit After Tax of 10-11%, according to a recent investor conference call. The company’s Q1 revenue was split with 55% attributed to its In Vitro Diagnostics (IVD) and MedTech segments, and 45% from Renewable Energy, which currently holds an order book of approximately Rs 3000 crore. Management highlighted a strategic focus on the healthcare/MedTech segment, driven by its proprietary technologies and higher margins, while also continuing to develop and acquire technologies like a recent breast cancer testing technology from C-MET. Lord’s Mark is exploring options to enter the hospital business, including developing a new facility or acquiring and converting an existing one, with a potential launch by March 2027, and is actively pursuing inclusion of preventive healthcare products in the Ayushman Bharat scheme.